Evidence map›Paper›PMID 39380080›Full record

ArticleTranslational neurodegeneration2024

Ultrasensitive detection of TDP-43 and amyloid-β protein aggregates using micelle-assisted seed amplification assay.

Sora Sakamoto, Yuichi Riku, Teiko Komori Nomura, Akio Kimura, Naoki Yamahara, Kazuki Ohuchi, Mari Yoshida, Yasushi Iwasaki, Takayoshi Shimohata, Masatoshi Inden and 1 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational neurodegeneration, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Comparison of TDP-43, NfL, and GFAP in cerebrospinal fluid and serum in Alzheimer's disease.European archives of psychiatry and clinical neuroscience · 2026
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sora SakamotoLaboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.
Yuichi RikuDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
Teiko Komori NomuraUnited Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.
Akio KimuraDepartment of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan.
Naoki YamaharaDepartment of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kazuki OhuchiLaboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Japan.
Takayoshi ShimohataDepartment of Neurology, Gifu University Graduate School of Medicine, Gifu, Japan.
Masatoshi IndenLaboratory of Medical Therapeutics and Molecular Therapeutics, Gifu Pharmaceutical University, Gifu, Japan.
Ryo HondaUnited Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan. ryohonda.rh@gmail.com.ORCID 0000-0003-3698-5975

Funding

JSPS KAKENHI JP22K06744JSPS KAKENHI JP22K07359JSPS KAKENHI JP23K06935
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyloid beta-PeptidesDNA-Binding ProteinsMicellesHumansProtein AggregatesAmyloid beta-PeptidesDNA-Binding ProteinsMicellesProtein AggregatesTARDBP protein, human

Identifiers

PMID39380080
PMCPMC11460235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.